AI assistant
Passage BIO, Inc. — Director's Dealing 2024
Feb 14, 2024
34849_dirs_2024-02-13_ce0f1ae7-3289-43ad-a892-4d02197f2b87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2021-08-16
Reporting Person: Forman Mark S (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-10 | Common Stock | M | 5000 | — | Acquired | 50269 | Direct |
| 2024-02-13 | Common Stock | S | 1638 | $.97 | Disposed | 48631 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-16 | Employee Stock Option (right to buy) | $10.84 | A | 130000 | Acquired | 2031-08-15 | Common Stock (130000) | Direct |
| 2022-02-10 | Employee Stock Option (right to buy) | $4.52 | A | 25000 | Acquired | 2032-02-09 | Common Stock (25000) | Direct |
| 2022-02-10 | Restricted Stock Unit | $ | A | 15000 | Acquired | Common Stock (15000) | Direct | |
| 2024-02-10 | Restricted Stock Unit | $ | M | 5000 | Disposed | Common Stock (5000) | Direct |
Footnotes
F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2: The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
F3: The stock option vests as to 25% of the total shares on August 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F4: The stock option vests as of 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F5: 1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.